ACOG logo

Alpha Cognition Inc

ACOG
Healthcare|Biotechnology|US
$8.29
+0.14 (+1.72%)
DCF Value
$6.49
Tangible Book / Share
$2.15
Cash / Share
$1.90
Next Earnings Report
Nov 11, 2026
EPS est. -$0.33 · Revenue est. $7.0M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (1)

Apr 2027
Est. completion
P4Alzheimer Disease
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT07633470n=150

Recent Press Releases

Alpha Cognition to Participate in Upcoming Investor Events
Nov 6, 2026 · Business Wire
Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business Update
Nov 2, 2026 · Business Wire
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
Oct 13, 2026 · Business Wire
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
Oct 6, 2026 · Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026 · Business Wire
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
Oct 1, 2026 · Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 9, 2026 · Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 1, 2026 · Business Wire
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
Aug 17, 2026 · Newsfile Corp
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
Aug 13, 2026 · Business Wire

SEC Filings (81)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 23, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Jul 24, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 23, 20268-KMaterial eventDocumentIndex
May 22, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 1, 20268-K/AMaterial eventDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 20, 20268-KMaterial eventDocumentIndex
Apr 14, 20268-KMaterial eventDocumentIndex
Mar 31, 202610-KAnnual reportDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 26, 20268-KMaterial eventDocumentIndex
Mar 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 23, 20268-KMaterial eventDocumentIndex
Feb 20, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 20, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 19, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 18, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 15, 20268-KMaterial eventDocumentIndex
Jan 13, 2026S-8Employee stock planDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex
Oct 15, 20258-K/AMaterial eventDocumentIndex
Oct 14, 20258-KMaterial eventDocumentIndex
Oct 3, 2025SC 13GPassive 5%+ stakeDocumentIndex
Oct 2, 20258-KMaterial eventDocumentIndex
Oct 1, 2025424B5Offering prospectusDocumentIndex
Sep 30, 2025424B5Offering prospectusDocumentIndex
Aug 29, 2025EFFECTDocumentIndex
Aug 29, 2025424B2Offering prospectusDocumentIndex
Aug 29, 2025424B3Offering prospectusDocumentIndex
Aug 22, 20258-KMaterial eventDocumentIndex